Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Utah fentanyl deaths and pill seizures surge as families testify at meeting
Loading...
Summary
A meeting speaker said fentanyl-related deaths in Utah rose 116% from 2014–2023, seizures of counterfeit fentanyl pills set records in 2023 and exceeded that total by mid-2024, and two family members shared testimony about relatives lost to overdoses.
At a public meeting, Speaker 1, a meeting participant, said deaths involving fentanyl in Utah rose 116% from 2014 through 2023 and that law-enforcement seizures of counterfeit fentanyl pills set records, while two family members shared testimony about relatives lost to overdoses.
The speaker said, “The number of fentanyl related deaths more than doubled between 2019 and 2020 alone,” and described the crisis as having “infiltrated our homes, our schools, our communities, our workplaces, taking lives and destroying lives at an unprecedented rate.” The speaker thanked two people identified as Mr. Puerta and Ms. Noring for sharing testimony and expressed sympathy for their losses.
The speaker gave a series of statistics to illustrate the trends: from 2014 through 2023, deaths involving fentanyl rose by 116 percent; the speaker said there were 23 deaths in 2014 and many more in subsequent years. The speaker also said that law-enforcement seized 664,200 fentanyl pills in Utah in 2023 and that the DEA’s Rocky Mountain Field Division had confiscated “well in excess” of that number by July 2024 — “close to 800,000 pills” in six months, according to the speaker.
The speaker contrasted the sharp rise in deaths from illicit fentanyl with a decline in deaths from prescription opioids, saying the increase in fentanyl-related deaths has outpaced gains made reducing prescription-opioid fatalities. The speaker framed the surge as a growing public-health and public-safety problem affecting families across Utah.
The meeting record provided no formal motions, votes, or staff directives related to the statistics or the testimony. The transcript excerpt does not specify which agency presented the data beyond the speaker’s reference to the DEA Rocky Mountain Field Division, nor does it list follow-up actions or new resource commitments.
The discussion combined data-driven remarks with personal testimony; the speaker noted that “in 2023 alone, over 600 times in Utah, someone returned home to find their son, their daughter, their sibling, their parent, had had lost their life due to a tragic opioid overdose,” language that the transcript records as part of the speaker’s remarks. The transcript does not provide additional details about proposed policy responses, funding requests, or specific programs for prevention and treatment during this meeting.
No formal decisions or votes on legislation or funding were recorded in the provided excerpt. The meeting contained testimony and data intended to document the scale of fentanyl-related harms in Utah; next steps, if any, were not specified in the transcript excerpt.

